Literature DB >> 15761233

Exercise and circulating insulin-like growth factor I.

Ulrika Berg1, Peter Bang.   

Abstract

Determinations of serum concentrations of total insulin-like growth factor I (tIGF-I) are important in the diagnosis, monitoring of treatment and safety evaluation of patients with growth disorders and/or metabolic disease. It is well established that tIGF-I status varies over time. Changes in tIGF-I levels in relation to an acute bout of exercise or repeated bouts, known as training, are likely to contribute to this variation. Serum tIGF-I has also been found to be of predictive value in growth prediction models employed before the start of growth hormone (GH) treatment. Furthermore, IGF-I generation tests have been suggested to be of value in the assessment of the growth response to GH administration in patients suspected of GH deficiency with or without some degree of GH insensitivity. This is discussed elsewhere in this issue. Recent progress in our understanding of growth hormone-dependent and -independent expression of the IGF1 gene in skeletal muscle and the role of sufficient energy intake during training for muscle and liver generation of IGF-I raises important questions regarding their relative contribution to the circulating pool of IGF-I. The present review is focused on circulating levels of tIGF-I in relation to a single bout of exercise or to a period of training. In addition, the expression of IGF-I locally in muscle in response to these stimuli will be discussed. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15761233     DOI: 10.1159/000080759

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  39 in total

Review 1.  Locomotor activities as a way of inducing neuroplasticity: insights from conventional approaches and perspectives on eccentric exercises.

Authors:  Pierre Clos; Romuald Lepers; Yoann M Garnier
Journal:  Eur J Appl Physiol       Date:  2021-01-02       Impact factor: 3.078

Review 2.  On the Run for Hippocampal Plasticity.

Authors:  C'iana Cooper; Hyo Youl Moon; Henriette van Praag
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 3.  Hepatokines-a novel group of exercise factors.

Authors:  Cora Weigert; Miriam Hoene; Peter Plomgaard
Journal:  Pflugers Arch       Date:  2018-10-18       Impact factor: 3.657

Review 4.  Neuroendocrine drivers of risk and resilience: The influence of metabolism & mitochondria.

Authors:  Susie Turkson; Alix Kloster; Peter J Hamilton; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2019-07-06       Impact factor: 8.606

5.  Chronic activity-based therapy does not improve body composition, insulin-like growth factor-I, adiponectin, or myostatin in persons with spinal cord injury.

Authors:  Todd A Astorino; Eric T Harness; Kara A Witzke
Journal:  J Spinal Cord Med       Date:  2014-08-17       Impact factor: 1.985

Review 6.  IGF-I/IGFBP system: metabolism outline and physical exercise.

Authors:  R Gatti; E F De Palo; G Antonelli; P Spinella
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

Review 7.  Perspective: Does brown fat protect against diseases of aging?

Authors:  Mark P Mattson
Journal:  Ageing Res Rev       Date:  2009-12-05       Impact factor: 10.895

8.  Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise.

Authors:  Mette Hansen; Satu O Koskinen; Susanne G Petersen; Simon Doessing; Jan Frystyk; Allan Flyvbjerg; Eva Westh; S Peter Magnusson; Michael Kjaer; Henning Langberg
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

Review 9.  Possible stimuli for strength and power adaptation: acute hormonal responses.

Authors:  Blair Crewther; Justin Keogh; John Cronin; Christian Cook
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

10.  Salivary free insulin-like growth factor-i levels: effects of an acute physical exercise in athletes.

Authors:  G Antonelli; R Gatti; M Prearo; E F De Palo
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.